Marked but transitory elevation of hepatic transaminases after subcutaneous calcium heparin administration.
Tison
T
T
Dazzi
F
F
Vianello
F
F
Radossi
P
P
Girolami
A
A
D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D000637:Transaminases / Q000097:blood / Q000187:drug effects*
D005343:Fibrinolytic Agents; C006871:calcium heparin; D006493:Heparin; D000637:Transaminases